GlaxoSmithKline PLC Block listing Interim Review (1725L)
May 11 2022 - 11:17AM
UK Regulatory
TIDMGSK
RNS Number : 1725L
GlaxoSmithKline PLC
11 May 2022
BLOCK LISTING SIX MONTHLY RETURN
Date: 11 May 2022
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan
--------------------------------------------------------
Period of return: From: 1 November 2021 To: 30 April 2022
------------------------ ------------------------- ------ ---------------------
Balance of unallotted securities under scheme(s) from
previous return: 265,519
--------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 0
--------------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): 221,300
--------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at
end of period: 44,219
--------------------------------------------------------
Name of applicant: GlaxoSmithKline plc
Name of scheme: GlaxoSmithKline plc Share Save Plan 2012
---------------------------------------------
Period of return: From: 1 November 2021 To: 30 April 2022
------------------------ -------------------- ----- ----------------
Balance of unallotted securities under scheme(s) from previous return: 3,069,147
---------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 0
---------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 1,695,652
---------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 1,373,495
---------------------------------------------
Name of contact: Victoria Whyte
Telephone number of contact: 020 8047 5000
---------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRMZGMKVMKGZZM
(END) Dow Jones Newswires
May 11, 2022 12:17 ET (16:17 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024